🔗 Share this article

Treasury head Rachel Reeves has revealed she is planning "focused measures to tackle cost of living pressures" in the upcoming financial statement.

In comments to the BBC, she stated that lowering inflation is a shared responsibility of both the government and the central bank.

The UK's inflation rate is expected to be the most elevated among the G7 industrialized countries this year and the following year.

Potential Energy Cost Interventions

Sources suggest the government could take action to reduce utility costs, such as by reducing the present 5% level of VAT applied on energy.

Another possibility is to lower some of the regulatory levies currently included in bills.

Fiscal Constraints and Expert Predictions

The government will receive the latest draft from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will show how much room there is for such actions.

The expectation from the majority of economists is that Reeves will have to introduce tax increases or spending cuts in order to fulfill her self-imposed debt limits.

Previously on the same day, estimates suggested there was a £22 billion deficit for the chancellor to resolve, which is at the more modest range of projections.

"There's a collective responsibility between the Bank of England and the government to continue tackling some of the causes of inflation," the Chancellor told reporters in Washington, at the yearly gatherings of the IMF and global financial institution.

Tax Commitments and Global Concerns

While a great deal of the focus has been on likely tax increases, the chancellor said the most recent figures from the fiscal watchdog had not changed her vow to campaign commitments not to raise rates on earnings tax, sales tax or social security contributions.

She attributed an "uncertain global environment" with rising geopolitical and commercial tensions for the fiscal revenue measures, likely to be focused on those "wealthiest."

Global Economic Disputes

Addressing worries about the UK's economic relations with China she said: "The UK's national security invariably are paramount."

Last week's declaration by Chinese authorities to increase export controls on critical minerals and other resources that are essential for advanced tech manufacturing led American leader the US President to propose an additional 100% tariff on imports from the Asian country, raising the prospect of an full-scale commercial conflict between the two economic giants.

The American finance chief described China's action "economic coercion" and "a global supply chain power grab."

Asked about accepting the American proposal to join its dispute with the Asian nation, Reeves said she was "very concerned" by Chinese measures and called on the Chinese government "not to put up barriers and limit trade."

She said the decision was "damaging for the international commerce and creates further obstacles."

"In my view there are fields where we must address Chinese policies, but there are also important opportunities to trade with China's economy, including financial services and other sectors of the economic system. We've got to get that equilibrium right."

The chancellor also stated she was collaborating with international partners "regarding our own critical minerals approach, so that we are reduced dependence."

NHS Medicine Costs and Funding

Reeves also admitted that the price the National Health Service pays for drugs could rise as a consequence of ongoing negotiations with the US government and its drugs companies, in exchange for lower tariffs and capital.

Some of the biggest global pharmaceutical manufacturers have said lately that they are either pausing or scrapping operations in the UK, with some attributing the insufficient payments they are obtaining.

Last month, the government science advisor said the price the health service spends on medicines would need to go up to halt businesses and pharmaceutical investment leaving the United Kingdom.

The Chancellor informed the BBC: "We have seen as a result of the pricing regime, that clinical trials, new drugs have not been offered in the United Kingdom in the way that they are in other EU nations."

"We want to make sure that patients receiving treatment from the National Health Service are can receive the finest essential medicines in the world. And so we are examining these issues, and... looking to obtain increased funding into Britain."